Analysis

Skip to filters. View results.

What’s new on our website

View results

Filter results by

Search Help
Currently selected filters that can be removed
Remove Remove "biotechnology" filter
Clear all

Keyword(s)

Subject

Year of publication

18 facets displayed. 0 facets selected.

Author(s)

19 facets displayed. 0 facets selected.

Survey or statistical program

17 facets displayed. 0 facets selected.

Content

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (111)

All (111) (0 to 10 of 111 results)

  • 1. Innovation in focus: Exploring trends in the development of advanced technology through patent applications
    Articles and reports: 22-20-00012024002
    Description: This article explores trends in patent applications made by Canadian-resident businesses for advanced technologies from 2001 to 2019, drawing on Eurostat's aggregation of high-tech patents. Approximately one-third of applications fall under high-tech categories, the bulk of which were associated with Communication, Computer, and Automated business equipment technologies. While these fields saw growth until 2012, a subsequent decline occurred, notably in Computer and Electronic Product Manufacturing. Biotechnology, Semiconductors, and Lasers showed limited dynamism, while aviation technology applications surged by nearly twentyfold over the period.
    Release date: 2024-05-21
  • 2. Biotechnology scientific activities in the federal government departments and agencies, 2008/2009 Archived
    Stats in brief: 88-001-X201000211095
    Geography: Canada
    Description:

    Data for fiscal year 2008/2009 comprise science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology research and development (R&D) and related scientific activities (RSA) in selected federal government departments and agencies.

    Release date: 2010-03-10
  • 3. Biotechnology scientific activities in federal government departments and agencies, 2007/2008 Archived
    Stats in brief: 88-001-X200900110802
    Geography: Canada
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2007/2008 were collected from selected federal government departments and agencies. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2009-03-04
  • 4. Biotechnology scientific activities in federal government departments and agencies, 2006/2007 Archived
    Stats in brief: 88-001-X200800210604
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2006/2007 were collected from selected federal government departments and agencies.The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2008-06-02
  • 5. Biotechnology spinoffs: Transferring knowledge from universities and government labs to the marketplace Archived
    Articles and reports: 88-003-X200800110581
    Geography: Canada
    Description:

    When an existing firm decides not to commercially develop a discovery, enterprising entrepreneurs may establish a spinoff organization to pursue the venture. Of the 532 biotechnology firms in Canada in 2005, 179 reported that they were spinoffs from another organization.

    Release date: 2008-05-22
  • 6. Start-up funding sources and biotechnology firm growth Archived
    Articles and reports: 88-003-X200700210326
    Geography: Canada
    Description:

    Although private investors and government funding agencies have learned that the biotechnology sector requires a funding model different from that of traditional manufacturing, there is a paucity of empirical research investigating the links between characteristics of the funding model and firm performance. The purpose of this article is to examine which funding sources have the greatest influence on firm growth.

    Release date: 2007-10-09
  • 7. Biotechnology scientific activities in federal government departments and agencies, 2005/2006 Archived
    Stats in brief: 88-001-X20070039614
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2005/2006 were collected from selected federal government departments and agencies. This information contributes to the work of the Canadian Biotechnology Strategy. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2007-05-11
  • 8. Innovative biotech firms: Early results from the 2005 Biotechnology Use and Development Survey Archived
    Articles and reports: 88-003-X20070019620
    Geography: Canada, Province or territory
    Description:

    Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.

    Release date: 2007-05-10
  • 9. Biotechnology scientific activities in federal government departments and agencies, 2004/2005 Archived
    Stats in brief: 88-001-X20060029114
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent allocated to biotechnology for the fiscal year 2004/2005 were collected from selected federal departments and agencies. Survey results contribute to the work of the Canadian Biotechnology Strategy. The S&T data collected for biotechnology are composed of expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and also the full-time equivalent associated with these activities.

    Release date: 2006-03-09
  • 10. The patenting activities of innovative biotechnology firms Archived
    Articles and reports: 88-003-X20050038769
    Geography: Canada
    Description:

    In Canada, innovative biotechnology firms invest large amounts to develop new biotechnology products and processes. In 2003, they invested nearly $1.5 billion in research and development (R&D). In biotechnology, the development process is long and costly, with no guarantee of success. Some firms that discover a new biotechnology product or process with potential industrial applications may want to protect it against any infringement. The patent is a tool preferred by innovative biotechnology firms to protect their invention. This short article describes the patenting activities of biotechnology firms in 2003 and examines the relationship between patents and funding.

    Release date: 2005-10-26
Stats in brief (8)

Stats in brief (8) ((8 results))

  • 1. Biotechnology scientific activities in the federal government departments and agencies, 2008/2009 Archived
    Stats in brief: 88-001-X201000211095
    Geography: Canada
    Description:

    Data for fiscal year 2008/2009 comprise science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology research and development (R&D) and related scientific activities (RSA) in selected federal government departments and agencies.

    Release date: 2010-03-10
  • 2. Biotechnology scientific activities in federal government departments and agencies, 2007/2008 Archived
    Stats in brief: 88-001-X200900110802
    Geography: Canada
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2007/2008 were collected from selected federal government departments and agencies. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2009-03-04
  • 3. Biotechnology scientific activities in federal government departments and agencies, 2006/2007 Archived
    Stats in brief: 88-001-X200800210604
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2006/2007 were collected from selected federal government departments and agencies.The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2008-06-02
  • 4. Biotechnology scientific activities in federal government departments and agencies, 2005/2006 Archived
    Stats in brief: 88-001-X20070039614
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2005/2006 were collected from selected federal government departments and agencies. This information contributes to the work of the Canadian Biotechnology Strategy. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2007-05-11
  • 5. Biotechnology scientific activities in federal government departments and agencies, 2004/2005 Archived
    Stats in brief: 88-001-X20060029114
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent allocated to biotechnology for the fiscal year 2004/2005 were collected from selected federal departments and agencies. Survey results contribute to the work of the Canadian Biotechnology Strategy. The S&T data collected for biotechnology are composed of expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and also the full-time equivalent associated with these activities.

    Release date: 2006-03-09
  • 6. Biotechnology scientific activities in federal government departments and agencies, 2003-2004 Archived
    Stats in brief: 88-001-X20050037933
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent allocated to biotechnology for the fiscal year 2003-2004 were collected from selected federal departments and agencies. Survey results contribute to the work of the Canadian Biotechnology Strategy.

    The S&T data collected for biotechnology are composed of expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and also the full-time equivalent associated with these activities.

    Release date: 2005-05-11
  • 7. Bioproducts Production and Development Survey 2015 Archived
    Stats in brief: 11-001-X2016356942
    Description: Release published in The Daily – Statistics Canada’s official release bulletin
    Release date: 2016-12-21
  • 8. Estimates of total spending on research and development in the health field in Canada, 1988 to 2001 (Science statistics) Archived
    Stats in brief: 88-001-X20020037899
    Description:

    Data on science and technology (S&T) expenditures and person-years allocated to biotechnology for the year 2000-2001 were collected from selected federal departments and agencies. The criterion for selection was significant activity in this field. Survey results contribute to the work of the Canadian Biotechnology Strategy.

    Release date: 2002-05-01
Articles and reports (102)

Articles and reports (102) (0 to 10 of 102 results)

  • 1. Innovation in focus: Exploring trends in the development of advanced technology through patent applications
    Articles and reports: 22-20-00012024002
    Description: This article explores trends in patent applications made by Canadian-resident businesses for advanced technologies from 2001 to 2019, drawing on Eurostat's aggregation of high-tech patents. Approximately one-third of applications fall under high-tech categories, the bulk of which were associated with Communication, Computer, and Automated business equipment technologies. While these fields saw growth until 2012, a subsequent decline occurred, notably in Computer and Electronic Product Manufacturing. Biotechnology, Semiconductors, and Lasers showed limited dynamism, while aviation technology applications surged by nearly twentyfold over the period.
    Release date: 2024-05-21
  • 2. Biotechnology spinoffs: Transferring knowledge from universities and government labs to the marketplace Archived
    Articles and reports: 88-003-X200800110581
    Geography: Canada
    Description:

    When an existing firm decides not to commercially develop a discovery, enterprising entrepreneurs may establish a spinoff organization to pursue the venture. Of the 532 biotechnology firms in Canada in 2005, 179 reported that they were spinoffs from another organization.

    Release date: 2008-05-22
  • 3. Start-up funding sources and biotechnology firm growth Archived
    Articles and reports: 88-003-X200700210326
    Geography: Canada
    Description:

    Although private investors and government funding agencies have learned that the biotechnology sector requires a funding model different from that of traditional manufacturing, there is a paucity of empirical research investigating the links between characteristics of the funding model and firm performance. The purpose of this article is to examine which funding sources have the greatest influence on firm growth.

    Release date: 2007-10-09
  • 4. Innovative biotech firms: Early results from the 2005 Biotechnology Use and Development Survey Archived
    Articles and reports: 88-003-X20070019620
    Geography: Canada, Province or territory
    Description:

    Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.

    Release date: 2007-05-10
  • 5. The patenting activities of innovative biotechnology firms Archived
    Articles and reports: 88-003-X20050038769
    Geography: Canada
    Description:

    In Canada, innovative biotechnology firms invest large amounts to develop new biotechnology products and processes. In 2003, they invested nearly $1.5 billion in research and development (R&D). In biotechnology, the development process is long and costly, with no guarantee of success. Some firms that discover a new biotechnology product or process with potential industrial applications may want to protect it against any infringement. The patent is a tool preferred by innovative biotechnology firms to protect their invention. This short article describes the patenting activities of biotechnology firms in 2003 and examines the relationship between patents and funding.

    Release date: 2005-10-26
  • 6. Canadian biotechnology activity, 2003 Archived
    Articles and reports: 88-003-X20050028021
    Geography: Canada
    Description:

    Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.

    Release date: 2005-06-20
  • 7. Biotechnology use and development Archived
    Articles and reports: 88-003-X20050017771
    Geography: Canada
    Description:

    Preliminary data indicate the biotechnology sector continued its phenomenal growth in Canada between 2001 and 2003, generating almost $4 billion in revenues. Biotechnology companies have more than quadrupled their revenues since 1997, making biotech a quickly growing activity.

    Release date: 2005-02-09
  • 8. Factors in biotechnology growth: Results of interviews with leaders of high growth biotechnology firms Archived
    Articles and reports: 88-003-X20040037432
    Geography: Canada
    Description:

    This article is based on a recent series of interviews with leaders of high growth biotechnology firms. It highlights the importance of financing, management strategies and qualified personnel for achieving high growth.

    Release date: 2004-10-29
  • 9. Biotechnology scientific activities in selected federal government departments and agencies, 2002-2003 Archived
    Articles and reports: 88-001-X20040077864
    Description:

    Data on science and technology (S&T) expenditures and person-years allocated to biotechnology for the year 2002-2003 were collected from selected federal departments and agencies. The criterion for selection was significant activity in this field. Survey results contribute to the work of the Canadian Biotechnology Strategy. The data collected for biotechnology are composed of research and development (R&D) and related scientific activities (RSA) expenditures, for intramural and extramural activities, by performer, and also the person-years associated with these activities.

    Release date: 2004-07-19
  • 10. Changes in the number of biotechnology innovative firms and revenues Archived
    Articles and reports: 88-003-X20040026930
    Geography: Canada
    Description:

    Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.

    Release date: 2004-06-30
Journals and periodicals (1)

Journals and periodicals (1) ((1 result))

  • 1. Innovation Analysis Bulletin Archived
    Journals and periodicals: 88-003-X
    Geography: Canada
    Description:

    The bulletin summarizes and highlights new results in the analysis of science, technology and the information society. The articles cover current issues in science and technology activities, advanced technologies, innovation in industry and electronic media. The bulletin is designed to be easily readable by non-experts.

    Release date: 2009-06-05
Report a problem or mistake on this page
Date modified:

Search help

How do I use the filters and the search box?

  • You can initiate a search by entering keywords or selecting filters (e.g., under Subject, Geography, etc.) on the left side of the page.

  • Filters can be used together or in any combination. Each time you select a filter, the results on the page are updated.

  • To start a new search, click on the Clear all button above the search box or deselect each filter.

  • Specified keywords and filters appear above the search box. You can deselect any or all the tags to refine or clear your search.

How do I refine my search?

  • You can enter keywords in the search box. It is not necessary to use “+” or “, “ or “AND”.

  • You can delete some or all of the keywords from your search string.

  • Quotes around keywords limit the search to a specific phrase.

    • For example, “labour force survey” will limit results to products containing this phrase.

  • Use “or” between keywords to obtain results that contain one or more search terms.

    • For example, labour or­ force or survey will limit results to products containing any or all of these words.

How does the search work?

  • This search looks for results that have your query term in the title, description, subject, geography, product number or other information about the product.

    • For example, when searching the term ‘Diseases’, all results with the word ‘Diseases’ in the title, description or tagged the subject appear.

  • The text within an article or publication are not searched. For full text searching of articles, use the site search.

Sort help

How are the results ordered?

The Sort by feature provides three options:

  • By date – sorts results by product release date starting with the most recent.
  • By relevance is only needed or beneficial when you use the search box and submit a search query. Results are ordered by a combination of where the search term appears in the content, e.g., if it appears in the title, it likely means the product is more relevant to your search; how up to date or new the content in the product is; how popular the product is; and other factors.
  • By title – sorts results alphabetically.

Sort help

How are the results ordered?

The Sort by feature provides four options:

  • By date – sorts results by product release date starting with the most recent.
  • By most popular – gives priority to results that are most frequently selected by users, followed by the most recent.
  • By relevance is only needed or beneficial when you use the search box and submit a search query. Results are ordered by a combination of where the search term appears in the content, e.g., if it appears in the title, it likely means the product is more relevant to your search; how up to date or new the content in the product is; how popular the product is; and other factors.
  • By title – sorts results alphabetically.